Free Trial

JCR Pharmaceuticals (JCRRF) Short Interest Ratio & Short Volume

JCR Pharmaceuticals logo
$4.57
0.00 (0.00%)
(As of 11/1/2024 ET)

JCR Pharmaceuticals Short Interest Data

JCR Pharmaceuticals (JCRRF) has a short interest of 305,200 shares. This marks a 1.40% increase in short interest from the previous month. The short interest ratio (days to cover) is 3,052.0, indicating that it would take 3,052.0 days of the average trading volume of 200 shares to cover all short positions.

Current Short Interest
305,200 shares
Previous Short Interest
301,000 shares
Change Vs. Previous Month
+1.40%
Dollar Volume Sold Short
$1.39 million
Short Interest Ratio
3,052.0 Days to Cover
Last Record Date
October 15, 2024
Today's Trading Volume
0 shares
Average Trading Volume
200 shares
Today's Volume Vs. Average
0%
Short Selling JCR Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for JCR Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

JCRRF Short Interest Over Time

JCRRF Days to Cover Over Time

JCRRF Percentage of Float Shorted Over Time

JCR Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024305,200 shares $1.39 million +1.4%N/A3052 $4.57
9/30/2024301,000 shares $1.41 million +0.2%N/A0 $4.70
9/15/2024300,300 shares $1.41 million -3.0%N/A3003 $4.70
8/31/2024309,700 shares $1.33 million -12.1%N/A0 $4.30
8/15/2024352,400 shares $1.52 million -7.3%N/A0 $4.30
7/31/2024380,200 shares $1.64 million -6.1%N/A3802 $4.30
7/15/2024405,000 shares $2.11 million -21.8%N/A0 $5.22
6/30/2024517,600 shares $2.70 million +15.8%N/A0 $5.22
6/15/2024447,000 shares $2.33 million -17.8%N/A0 $5.22
5/31/2024544,000 shares $2.84 million +0.8%N/A0 $5.22
5/15/2024539,500 shares $2.82 million +5.3%N/A0 $5.22
4/30/2024512,400 shares $2.67 million -7.0%N/A0 $5.22
4/15/2024551,200 shares $2.88 million -6.7%N/A5512 $5.22
3/31/2024590,800 shares $3.66 million -6.0%N/A0 $6.20
3/15/2024628,800 shares $3.90 million -20.6%N/A0 $6.20
2/29/2024791,700 shares $4.91 million -2.7%N/A0 $6.20
2/15/2024813,800 shares $5.05 million +5.5%N/A8138 $6.20
1/15/2024726,700 shares $6.57 million -3.3%N/A0 $9.04
12/31/2023751,100 shares $6.79 million -0.1%N/A0 $9.04
12/15/2023752,000 shares $6.80 million -3.2%N/A0 $9.04
11/30/2023776,700 shares $7.02 million -5.1%N/A0 $9.04
11/15/2023818,200 shares $7.40 million +0.2%N/A0 $9.04
10/31/2023816,300 shares $7.38 million +0.6%N/A0 $9.04
10/15/2023811,100 shares $7.33 million -1.1%N/A8111 $9.04
9/30/2023820,000 shares $8.29 million -5.8%N/A8200 $10.11
9/15/2023870,600 shares $8.24 million +3.7%N/A0 $9.47
8/31/2023839,900 shares $7.95 million -1.6%N/A0 $9.47
8/15/2023853,300 shares $8.08 million -4.8%N/A0 $9.47
7/31/2023896,300 shares $8.49 million +20.9%N/A8963 $9.47
7/15/2023741,600 shares $7.04 million +13.4%N/A0 $9.49
6/30/2023654,100 shares $6.21 million -2.9%N/A6541 $9.49
6/15/2023673,300 shares $7.24 million +9.4%N/A0 $10.76
5/31/2023615,400 shares $6.62 million +53.9%N/A0 $10.76
5/15/2023400,000 shares $4.30 million +11.6%N/A0 $10.76
4/30/2023358,500 shares $3.86 million +17.5%N/A0 $10.76
4/15/2023305,000 shares $3.28 million +8.2%N/A3050 $10.76
3/31/2023281,800 shares $2.93 million +4.3%N/A2818 $10.40
3/15/2023270,200 shares $2.81 million -5.4%N/A2702 $10.40
2/28/2023285,700 shares $3.54 million -0.2%N/A0 $12.38
2/15/2023286,300 shares $3.54 million -10.5%N/A1431.5 $12.38
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

1/31/2023319,700 shares $6.15 million +11.4%N/A0 $19.24
1/15/2023287,100 shares $5.52 million -13.1%N/A0 $19.24
12/30/2022330,400 shares $6.36 million -5.9%N/A3304 $19.24
12/15/2022351,100 shares $6.76 million -65.0%N/A1.1 $19.24
11/30/20221,004,100 shares $19.32 million +120.8%N/A0 $19.24
11/15/2022454,800 shares $8.75 million +14.6%N/A0 $19.24
10/31/2022397,000 shares $7.64 million +3.9%N/A0 $19.24
10/15/2022382,200 shares $7.35 million +1.0%N/A3822 $19.24
9/30/2022378,300 shares $7.28 million +0.3%N/A3783 $19.24
9/15/2022377,200 shares $7.26 million -63.3%N/A1.3 $19.24
8/31/20221,027,200 shares $19.76 million +22.5%N/A0 $19.24
8/15/2022838,500 shares $16.13 million +39.5%N/A8385 $19.24
7/31/2022601,000 shares $11.56 million -34.2%N/A751.3 $19.24
7/15/2022912,800 shares $16.38 million +91.5%N/A0 $17.95
6/30/2022476,600 shares $8.55 million +2.1%N/A0 $17.95
6/15/2022466,800 shares $8.38 million +0.5%N/A0 $17.95
5/31/2022464,400 shares $8.34 million -8.5%N/A0 $17.95
5/15/2022507,600 shares $9.11 million -1.8%N/A0 $17.95
4/30/2022517,100 shares $9.28 million +3.8%N/A0 $17.95
4/15/2022498,400 shares $8.95 million +3.4%N/A0 $17.95
3/31/2022482,000 shares $8.65 million -14.4%N/A0 $17.95
3/15/2022563,300 shares $10.11 million -26.9%N/A0 $17.95
2/28/2022771,000 shares $13.84 million +3.4%N/A0 $17.95
2/15/2022745,500 shares $13.38 million +1.0%N/A0 $17.95
1/31/2022738,500 shares $13.26 million -23.6%N/A2461.7 $17.95
1/15/2022967,100 shares $26.98 million +43.5%N/A0 $27.90
12/31/2021674,100 shares $18.81 million +25.1%N/A0 $27.90
12/15/2021538,700 shares $15.03 million +16.6%N/A0 $27.90
11/30/2021462,000 shares $12.89 million -1.6%N/A0 $27.90
11/15/2021469,400 shares $13.10 million +11.4%N/A0 $27.90
10/29/2021421,500 shares $11.76 million -4.8%N/A0 $27.90
10/15/2021442,800 shares $12.35 million -1.3%N/A0 $27.90
9/30/2021448,400 shares $12.51 million -18.4%N/A0 $27.90
9/15/2021549,600 shares $15.33 million -36.9%N/A5496 $27.90
8/31/2021871,500 shares $24.31 million +22.7%N/A0 $27.90
8/13/2021710,100 shares $19.81 million +57.9%N/A0 $27.90
7/30/2021449,800 shares $12.55 million -7.2%N/A0 $27.90
7/15/2021484,600 shares $13.52 million -1.8%N/A0 $27.90
6/30/2021493,300 shares $13.76 million +0.7%N/A0 $27.90
6/15/2021490,100 shares $13.67 million +1.9%N/A0 $27.90
5/28/2021481,000 shares $13.42 million +16.6%N/A0 $27.90
5/14/2021412,700 shares $11.51 million -7.2%N/A0 $27.90
4/30/2021444,500 shares $12.40 million -22.4%N/A4445 $27.90
4/15/2021573,100 shares $19.40 million +51.4%N/A0 $33.85
3/31/2021378,500 shares $12.81 million +42.0%N/A0 $33.85
3/15/2021266,500 shares $9.02 million +27.6%N/A0 $33.85
2/26/2021208,900 shares $7.07 million +25.4%N/A2089 $33.85
2/12/2021166,600 shares $0.00 -33.6%N/A0 $0.00
1/29/2021251,000 shares $0.00 +48.9%N/A0 $0.00
1/15/2021196,800 shares $0.00 +37.4%N/A0 $0.00
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

12/31/2020125,700 shares $0.00 -36.1%N/A0 $0.00

JCRRF Short Interest - Frequently Asked Questions

What is JCR Pharmaceuticals' current short interest?

Short interest is the volume of JCR Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 305,200 shares of JCRRF short. Learn More on JCR Pharmaceuticals' current short interest.

What is a good short interest ratio for JCR Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JCRRF shares currently have a short interest ratio of 3,052.0. Learn More on JCR Pharmaceuticals's short interest ratio.

Is JCR Pharmaceuticals' short interest increasing or decreasing?

JCR Pharmaceuticals saw a increase in short interest in October. As of October 15th, there was short interest totaling 305,200 shares, an increase of 1.4% from the previous total of 301,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does JCR Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to JCR Pharmaceuticals: Bayer Aktiengesellschaft (0.00%), Astellas Pharma Inc. (0.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short JCR Pharmaceuticals stock?

Short selling JCRRF is an investing strategy that aims to generate trading profit from JCR Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against JCR Pharmaceuticals?

A short squeeze for JCR Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JCRRF, which in turn drives the price of the stock up even further.

How often is JCR Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JCRRF, twice per month. The most recent reporting period available is October, 15 2024.




This page (OTCMKTS:JCRRF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners